 AngioDynamics Inc NASDAQ: ANGO has reported a Q3 FY22 adjusted EPS of 0.03, ahead of the consensus of 0.01, and better than the consensus of 0.02 reported a year ago. Q3 sales increased 3.9 YY to 73.97 million, missing the analyst consensus of 76.32 million. 